ProDetect® is a series of tests by Medical Innovation Ventures (Mediven) that screens for viruses, drug presence, antigens and antibodies.
GenoAmp® provides screening and confirmatory molecular tests for COVID-19 detection, by screening the RdRP and S genes, and confirming by using N gene.
ColonAiQ® is poised to redefine the landscape of CRC screening, providing a powerful tool for identifying these conditions at their earliest stages.